New Delhi: Serum Institute of India (SII) is expected to sign a contract with the Central government to supply COVID-19 vaccine at Rs 250 per dose, Business Standard reported.
SII, which is the world’s largest vaccine producer, along with Pfizer India have applied for emergency approval of their vaccines in India.
SII CEO Adar Poonawalla had earlier revealed that the vaccine would be priced around Rs 1,000 per dose in the private market. He had also assured that the vaccine would be first supplied to Indians before exporting.
SII is producing the vaccine developed by AstraZeneca and Oxford University.
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
Hyderabad: Allu Arjun’s woes keep mounting. In a worrying development, protesters stormed Allu Arjun’s Jubilee…
This website uses cookies.